Skip to main content

A note on sample size determination for bioequivalence studies with high-order crossover designs.

Journal articles  - Journal Article
Chen, KW; Chow, SC; Li, G
Published in: J Pharmacokinet Biopharm
December 1997

Similar to Liu and Chow, approximate formulas for sample size determination are derived based on Schuirmann's two one-sided tests procedure for bioequivalence studies for the additive and the multiplicative models under various higher order crossover designs for comparing two formulations of a drug product. The higher order crossover designs under study include Balaam's design, the two-sequence dual design, and two four-period designs (with two and four sequences), which are commonly used for assessment of bioequivalence between formulations. The derived formulas are simple enough to be carried out with a pocket calculator. The number of subjects required for each of the four higher order designs are tabulated for selected powers and various parameter values.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Pharmacokinet Biopharm

DOI

ISSN

0090-466X

Publication Date

December 1997

Volume

25

Issue

6

Start / End Page

753 / 765

Location

United States

Related Subject Headings

  • Therapeutic Equivalency
  • Sample Size
  • Pharmacology & Pharmacy
  • Humans
  • Cross-Over Studies
  • Clinical Trials as Topic
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, K. W., Chow, S. C., & Li, G. (1997). A note on sample size determination for bioequivalence studies with high-order crossover designs. J Pharmacokinet Biopharm, 25(6), 753–765. https://doi.org/10.1023/a:1025738019069
Chen, K. W., S. C. Chow, and G. Li. “A note on sample size determination for bioequivalence studies with high-order crossover designs.J Pharmacokinet Biopharm 25, no. 6 (December 1997): 753–65. https://doi.org/10.1023/a:1025738019069.
Chen KW, Chow SC, Li G. A note on sample size determination for bioequivalence studies with high-order crossover designs. J Pharmacokinet Biopharm. 1997 Dec;25(6):753–65.
Chen, K. W., et al. “A note on sample size determination for bioequivalence studies with high-order crossover designs.J Pharmacokinet Biopharm, vol. 25, no. 6, Dec. 1997, pp. 753–65. Pubmed, doi:10.1023/a:1025738019069.
Chen KW, Chow SC, Li G. A note on sample size determination for bioequivalence studies with high-order crossover designs. J Pharmacokinet Biopharm. 1997 Dec;25(6):753–765.

Published In

J Pharmacokinet Biopharm

DOI

ISSN

0090-466X

Publication Date

December 1997

Volume

25

Issue

6

Start / End Page

753 / 765

Location

United States

Related Subject Headings

  • Therapeutic Equivalency
  • Sample Size
  • Pharmacology & Pharmacy
  • Humans
  • Cross-Over Studies
  • Clinical Trials as Topic
  • 3214 Pharmacology and pharmaceutical sciences